Compare BLLN & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | GTX |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | Switzerland |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.5B |
| IPO Year | N/A | 2021 |
| Metric | BLLN | GTX |
|---|---|---|
| Price | $96.06 | $31.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $126.71 | $20.40 |
| AVG Volume (30 Days) | 771.8K | ★ 3.0M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 20.63 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $3,584,000,000.00 |
| Revenue This Year | $46.29 | $4.16 |
| Revenue Next Year | $30.14 | $3.27 |
| P/E Ratio | ★ N/A | $67.06 |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $61.96 | $9.58 |
| 52 Week High | $138.70 | $34.34 |
| Indicator | BLLN | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 60.06 |
| Support Level | $79.07 | $17.01 |
| Resistance Level | $97.36 | $34.34 |
| Average True Range (ATR) | 7.92 | 1.26 |
| MACD | 0.95 | -0.44 |
| Stochastic Oscillator | 58.11 | 48.36 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.